search for
or search by
Results 1 - 20 of 361
Aptar Pharma’s Preservative-Free Multidose Dispenser Chosen for the First Time
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the US prescription market for the first time with Allergan’s RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05%.
Nemera Wins Editor’s Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral Drug Association (PDA), recently announced the winners for the INTERPHEX Exhibitor Awards for 2017.
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami is setting the industry standard for project management and transparency with its new Customer Portal and Mobile Application: Alcami OnDemand™. The initial phase will concentrate on the sample submission process within its Analytical Testing offering.
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines.
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America.
Avomeen Analytical Services Announces New CEO
Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named its CEO. High Street Capital of Chicago and Avomeen founder and retiring CEO Shri Thanedar, PhD, made the announcement.
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, according to business intelligence provider GBI Research.
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has recently signed a license agreement with Gerresheimer.
Accelerating Development of Enabled Formulations for Poorly Soluble Drugs
Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. Often solubility issues are often only discovered when the drug is first administered in clinical trials....
Capnia Completes Merger With Essentialis, Creating Rare Disease Therapeutics Company
Capnia, Inc., focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, recently announced it has completed its previously announced merger with privately held Essentialis, Inc. effective March 7, 2017.
Head & Neck Cancer Market Offers Fertile Investment Ground as Disease Understanding Improves
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, potentially transforming the clinical and commercial landscape, according to business intelligence firm GBI Research.
Kitov Announces License Agreement for KIT-302 in South Korea
Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, recently announced it has signed a definitive License Agreement for its lead product candidate, KIT-302, which was developed to simultaneously treat pain caused by osteoarthritis and to treat hypertension, for the territory of South Korea with Kuhnil Pharmaceutical Co. Ltd.
Essen BioScience to be Acquired for $320 Million
Essen BioScience Inc., a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research applications, recently signed an agreement to be acquired by Sartorius, a leading partner to the biopharmaceutical industry and laboratories.
nLife Therapeutics Enters Research Collaboration With WAVE Life Sciences
nLife Therapeutics S.L. recently announced the initiation of a research collaboration aimed at exploring cell-specific targeting of nucleic-acid therapeutics in the central nervous system (CNS) with WAVE Life Sciences Ltd., a genetic medicines company focused on developing therapies for patients impacted by rare genetic diseases.
Gerresheimer AG Appoints New CEO
Dr. Christian Fischer will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive Officer on September 1, 2017.
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with currently four tabletop games and three children's books under our belt.
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new patent.
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site.
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications.


















- SHL


Click here to see the showcases


INTERPHEX
March 21-23
New York, NY

PDA Annual Meeting
April 3-5
Anaheim, CA

RDD (Respiratory Drug Delivery)
April 25-28
Nice, France

Pre-filled Syringes East Coast
April 26-27
Boston, MA


AAPS National Biotechnology Meeting
May 1-3
San Diego, CA

Innovation Networking Summit & Table-top Exhibition
May 4-5
Hilton Hotel, Parsippany, NJ

CPhI North America & Informex
May 16-18
2017 Philadelphia, PA

BIO 2017
June 19 - 22
San Diego, CA

Controlled Release Society Meeting
July 16-19 Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Nienna, Austria

AAPS
November 12-17
San Diego, CA

Advertisement

 



Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions